Critical Care
The Role of the Nephrologist in Management of Poisoning and Intoxication: Core Curriculum 2022.
9 Feb, 2022 | 08:46h | UTC
Review | Emergency blood transfusion for trauma and perioperative resuscitation.
9 Feb, 2022 | 08:22h | UTC
Clinical update on COVID-19 for the emergency clinician: Presentation and evaluation.
7 Feb, 2022 | 08:56h | UTC
ERC-ESICM guidelines on temperature control after cardiac arrest in adults.
7 Feb, 2022 | 08:44h | UTCERC-ESICM guidelines on temperature control after cardiac arrest in adults – Intensive Care Medicine (if the link is paywalled, try this one)
Related:
Commentary on Twitter
Temperature control post ROSC @ERC_resus @ESICM guidelines:
🌡 monitor (core T) + prevent fever (min 72h)
❄️ insufficient evidence for/against 32-36°C or early cooling
Not recommended
🌡 active rewarming (mild hypothermia)
🚑 pre 🏥 cooling (cold fluids)https://t.co/w6X8fLInzf pic.twitter.com/U8TWG1oUyV— Intensive Care Medicine (@yourICM) January 28, 2022
M-A: Tranexamic acid in aneurysmal subarachnoid hemorrhage does not improve clinical outcomes or mortality.
7 Feb, 2022 | 08:26h | UTCEfficacy and safety of tranexamic acid in aneurysmal subarachnoid hemorrhage: A meta-analysis of randomized controlled trials – The American Journal of Emergency Medicine (link to abstract – $ for full-text)
M-A: The effect of Dexmedetomidine as a sedative agent for mechanically ventilated patients with sepsis.
7 Feb, 2022 | 08:15h | UTC
Consensus Statement: Preoperative Management of Medications for Neurologic Diseases.
4 Feb, 2022 | 10:00h | UTCPreoperative Management of Medications for Neurologic Diseases – Mayo Clinic Proceedings
Related: Consensus Statement: Preoperative management of medications for psychiatric diseases.
Podcast: Infective Endocarditis Pearls.
4 Feb, 2022 | 08:27h | UTCInfective Endocarditis Pearls – The Curbsiders
Perspective: The origins, development, and context of the Lancet Commission on the Value of Death – “Death has turned from being a family, social, and cultural event to primarily a medical event”.
3 Feb, 2022 | 08:51h | UTCThe origins, development, and context of the Lancet Commission on the Value of Death – The BMJ
Cluster randomized controlled trial: An innovative telemedical network to improve infectious disease management in critically ill patients and outpatients.
3 Feb, 2022 | 08:53h | UTCRelated:
The “Choosing Wisely” initiative in infectious diseases – German Society of Infectious Diseases (link to abstract – $ for full-text)
Infectious Diseases Society of America: Five Things Physicians and Patients Should Question
Evaluation and management of traumatic pneumothorax: A Western Trauma Association critical decisions algorithm.
3 Feb, 2022 | 08:46h | UTC
M-A: Impact of Ketamine on analgosedative consumption in critically ill patients.
2 Feb, 2022 | 08:44h | UTCRelated:
Perspective: The ongoing saga of normal saline vs. balanced fluids.
2 Feb, 2022 | 08:43h | UTCThe ongoing saga of normal saline versus balanced fluids – First10EM
Original studies:
Related:
Takotsubo Syndrome: A review of presentation, diagnosis and management.
2 Feb, 2022 | 08:25h | UTCRelated:
International Expert Consensus Document on Takotsubo Syndrome
International Registry: 16.6% of Patients with Takotsubo Syndrome Have Underlying Malignancy
Systematic Review: Long-Term Prognosis and Outcome Predictors in Takotsubo Syndrome
Cohort Study: Hospital Readmission Following Takotsubo Syndrome
DIC in Pregnancy: Pathophysiology, clinical characteristics, diagnostic scores, and treatments.
2 Feb, 2022 | 08:27h | UTC
Observational study suggests Ceftaroline has comparable efficacy vs. Daptomycin for the treatment of Methicillin-Resistant Staphylococcus aureus bloodstream infection.
2 Feb, 2022 | 08:07h | UTC
Commentary on Twitter
New in OFID: A multicenter retrospective observational cohort study found no difference in treatment failure or mortality between MRSA bloodstream infections treated with ceftaroline or daptomycin.
📄: https://t.co/3QB5JXd8s5@PaulSaxMD @DrJLi @FungalDoc @IDpharmresearch pic.twitter.com/zNa9XRWP8F
— IDSA (@IDSAInfo) December 29, 2021
SCAI SHOCK Cardiogenic Shock Classification Expert Consensus Update.
1 Feb, 2022 | 09:53h | UTCNews Release: SCAI releases updated expert consensus to SCAI SHOCK classification – Society for Cardiovascular Angiography and Interventions
Commentaries:
SCAI SHOCK: Update Refines Cardiogenic Shock Classification – TCTMD
SCAI Releases Updated Expert Consensus to SCAI SHOCK Classification – American College of Cardiology
Commentaries on Twitter
.@SCAI SHOCK stage is an indication of shock severity & comprises one component of mortality risk prediction in pts w/ CS, along w/ etiology/phenotype & other risk modifiers; a 3-axis model of risk stratification in CS has been proposed. Learn more: https://t.co/tnh2JFhHzN #JACC pic.twitter.com/yK2ye9wcd0
— JACC Journals (@JACCJournals) January 31, 2022
SCAI SHOCK Stage Classification Expert Consensus Update released today in the inaugural issue of @MyJSCAI and also in @JACCJournals. Thank you to endorsing societies @ACCinTouch @american_heart @ACEPNow @escardio @ACVCPresident @ISHLT @SCCM @STS_CTsurgery https://t.co/GHrYn5I5WO pic.twitter.com/Y0mKC0zONu
— SCAI (@SCAI) January 31, 2022
The Lancet Commission: Experts warn of the increasing overmedicalization of death, call for radical rethink of how society cares for dying people.
1 Feb, 2022 | 09:55h | UTCHomepage: Lancet Commission on the Value of Death (free registration required for all articles)
Report of the Lancet Commission on the Value of Death: bringing death back into life
The precariousness of balancing life and death
Ros Taylor: seeing palliative care as relational
Commentary on Twitter (thread – click for more)
Increasing overmedicalisation at the end of life is denying people & their families a good death.
Towards a compassionate community model: The Lancet #ValueofDeath Commission calls for a radical rethink of care for the dying & attitudes to death. https://t.co/DpJiu1tOcV pic.twitter.com/FU9MgCO1J6
— The Lancet (@TheLancet) January 31, 2022
Observational study: Pharmacist involvement in the care of critically ill patients may reduce resource utilization, adverse drug events, and medical costs.
1 Feb, 2022 | 09:47h | UTC
Commentary from the author on Twitter (thread – click for more)
PHARM-CRIT Study
👩🔬 215 ICU PharmDs at 85 centers
💊55,926 accepted interventions on 27,681 patients over 3,148 shifts
💵$23,404,089 cost avoidance; monetary benefit-to-cost ratio for ICU pharmacists $3.3:1 – $9.6:1@SCCM_CPP @SCCM #TwitteRx #PharmICU https://t.co/Hv4jPwU6eb— Megan Rech, PharmD, MS (@MeganARech) December 16, 2021
Consensus: Nephrotoxins and acute kidney injury.
1 Feb, 2022 | 08:46h | UTC
M-A: Vasopressin and glucocorticoids for in-hospital cardiac arrest.
1 Feb, 2022 | 08:43h | UTC
Commentary on Twitter
Systemic review and meta analysis post VAM-IHCA.
▶️ Moderate certainty for benefit with steroids and vasopressin on ROSC
▶️ Less certainty for longer term outcomes @mathiasholmb@LarsWAndersen1 @AsgerGranfeldthttps://t.co/K3jZ1gBs1h— Critical Care Reviews (@CritCareReviews) January 4, 2022
Review: Multidisciplinary management of tracheobronchial injury.
1 Feb, 2022 | 08:17h | UTCMultidisciplinary management of tracheobronchial injury – European Respiratory Review
FDA halts use of antibody drugs that don’t work vs. Omicron.
30 Jan, 2022 | 14:35h | UTCFDA halts use of antibody drugs that don’t work vs. omicron – Associated Press
ELSO Guidelines for adult and pediatric extracorporeal membrane oxygenation circuits.
30 Jan, 2022 | 14:25h | UTCELSO Guidelines for Adult and Pediatric Extracorporeal Membrane Oxygenation Circuits – ASAIO Journal
Commentary on Twitter
The new ELSO guidelines, describing #ECMO circuits for all
patient populations, adult and pediatric, are now available, open access on @asaiojournal These consensus guidelines describe safe practice based on extensive experience.
Download full text #FOAMcchttps://t.co/Miu9sbY2gs pic.twitter.com/HU6zCwX031— ELSO (@ELSOOrg) January 28, 2022
Guideline Summary: Management of the top 10 most common immune-related adverse events in patients treated with immune checkpoint inhibitor therapy.
30 Jan, 2022 | 14:11h | UTCOriginal Article: ASCO Guideline Update: Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy.
Related:
Clinical practice guideline on immune checkpoint inhibitor-related adverse events.
NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities (several resources on the subject)


